Research
Neural
Innovative therapeutics focused on hunger control are being considered for patients with rare genetic obesities.
Clinicians may consider new pharmacological options for managing hunger in patients with rare genetic obesities.
StrongSupportsmedium confidence
The better understanding of the molecular causes of rare genetic obesities and its associated phenotype involving the hypothalamus allows today to consider innovative therapeutics focused on hunger control.
Why this rating
The abstract discusses a narrative review, indicating a comprehensive overview of the topic.
Source
Novel therapeutics in rare genetic obesities: A narrative review
Béatrice Dubern et al. · Pharmacological Research · 2023
reviewCited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →